Head-to-Head Superiority (SURMOUNT-5): The SURMOUNT-5 trial, with detailed results published in The New England Journal of Medicine on May 11, 2025, directly compared Tirzepatide (Zepbound) with semaglutide (Wegovy)
People who are pregnant, have a personal or family history of certain thyroid cancers, or have a recent history of pancreatitis need careful review
K.FrizzellR
Importantly, genetic insights into peptide pathways should be interpreted as predisposition information, not absolute predictors of medication efficacy or safety
Endocrine (2014) 46:55460
Were highlighting how 0g of sugar, 160 calories, 27 vitamins and minerals, and 6g of fiber work together with 25g of plant-based protein to support meaningful health goals